Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vysioneer
Cambridge, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Vysioneer's AI platform enables lesion-level insights to accelerate oncology drug development by improving the accuracy of treatment efficacy assessments. Their technology has demonstrated high concordance with independent readers in Phase III studies, such as the CROWN study with Pfizer, suggesting potential to improve endpoint evaluation and predict systemic progression from intracranial tumor response.
The company’s flagship product, VBrain, automates brain tumor contouring for radiosurgery/radiotherapy planning and has been adopted by hospitals internationally through partnerships.
No direct therapeutics or drugs are developed by the company.
- Therapeutic areas
- Oncology
- Modalities
- AI-powered analytics/software
- Industry
- Medical Imaging
02
Partnerships
MC Medical/Mitsubishi Corporation subsidiary (Japan market entry/VBrain deployment)Stanford Cancer InstitutePfizer (clinical trial collaboration – CROWN study)GE Healthcare
Beyond the preview
Go deeper on Vysioneer.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vysioneer.